One vs twelve month aspirin after percutaneous coronary intervention for acute myocardial infarction: individual patient-data analysis of TARGET-FIRST and ULTIMATE-DAPT trials
Abstract
Giuseppe Tarantini, Xiaojuan Zhang, Luca Nai Fovino, Jing Kan, Zhen Ge, Guillaume Cayla, Pieter C Smits, Benjamin Honton, Valeria Paradies, Yann Poezevara,
// Source
Authors: Giuseppe Tarantini, Xiaojuan Zhang, Luca Nai Fovino, Jing Kan, Zhen Ge, Guillaume Cayla, Pieter C Smits, Benjamin Honton, Valeria Paradies, Yann Poezevara, David Bouchez, Xiaofei Gao, Bilal Mohydin, Fentang Gao, Yibing Shao, Lianglong Chen, Gregg W. Stone, Shao-Liang Chen
Institutions: University of Padua, Icahn School of Medicine at Mount Sinai, Qingdao University, Nanjing Medical University, Xiamen University, Xiamen University of Technology, Punjab Institute of Cardiology, Université de Montpellier, Hôpital d'instruction des Armées Percy, Université de Nîmes, Qingdao Municipal Hospital, Gansu Provincial Hospital, Maasstad Ziekenhuis, Clinique Pasteur, Cardiovascular European Research Center